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Protein–protein interactionMolybdoenzymes contain a molybdenum cofactor in their active site to catalyze various redox reac-
tions in all domains of life. To decipher crucial steps during their biogenesis, the TorA molybdoen-
zyme of Escherichia coli had played a major role to understand molybdoenzyme maturation process
driven by speciﬁc chaperones. TorD, the speciﬁc chaperone of TorA, is also involved in TorA protec-
tion. Here, we show that immature TorA (apoTorA) is degraded in vivo and in vitro by the Lon pro-
tease. Lon interacts with apoTorA but not with holoTorA. Lon and TorD compete for apoTorA binding
but TorD binding protects apoTorA against degradation. Lon is the ﬁrst protease shown to eliminate
an immature or misfolded molybdoenzyme probably by targeting its inactive catalytic site.
Structured summary of protein interactions:
Lon cleaves apoTorA by enzymatic study (View interaction)
apoTorA binds to Lon by surface plasmon resonance (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Molybdoenzymes are widespread oxidoreductases found in all
domains of life. In Escherichia coli, 19 molybdoenzymes have been
identiﬁed and classiﬁed into three families: the xanthine oxidase
family, the sulﬁte oxidase family and the DMSO reductase family,
according to the type of molybdenum cofactor they bind [1,2]. In-
deed, although the molybdenum cofactor presents a basal common
structure, a pterin derivative (MPT) that is coordinated to a molyb-
denum atom (MoMPT), a variability of the cofactor is achieved by
attachment of a nucleotide to the MPT moiety [3]. Biosynthesis
of the molybdenum cofactor involved a four-step pathway [3,4].
The DMSO reductase family includes enzymes that present in their
catalytic site a bis molybdopterin guanine dinucleotide (bisMGD).
Among them, the trimethylamine oxide (TMAO) reductase TorA
has been extensively studied [1,5]. The expression of torA is tightly
regulated by the presence of TMAO, the substrate, reduced by TorA
into the volatile trimethylamine [6]. TorA is synthesised in the
cytoplasm where it acquires the bisMGD form of the molybdenum
cofactor in a deep cleft located on one side of its structure [7]. Afterthe insertion of the cofactor, TorA is translocated to the periplasm
by the TATmachinery that is speciﬁcally dedicated to export folded
proteins across the membrane [8,9]. During its cytoplasmic life,
TorA is escorted by its speciﬁc chaperone TorD. TorD plays impor-
tant roles in TorA protection against proteases and in the acquisi-
tion of the bisMGD [10,11]. When cells experience stressful
conditions, TorD becomes crucial for TorA biogenesis. In a TorD
strain grown at 37 C, most of the pool of apoTorA is degraded
and only 30% of the protein is matured and correctly exported to
the periplasm [10,12]. Under condition of thermal stress (42 C),
neither TMAO reductase activity nor TorA protein is detected in
the TorD strain [13]. Likewise, when molybdenum or molybde-
num cofactor is limiting, a situation arising when several molybdo-
enzymes are produced concomitantly, apoTorA is totally degraded
in the absence of TorD. However, in the presence of TorD, a pool of
apoTorA is maintained transiently and can be matured when the
cofactor becomes available [14].
TorA stability and maturation involve TorD binding to the apo-
form of TorA at two distinct sites: one on the leader peptide of the
apoprotein at its N-terminal end, and the second on the core of the
protein [10,11,15]. The integrity of the apoTorA signal sequence is
TorD-dependent. In the absence of the chaperone, apoTorA is trun-
cated of its ﬁrst 35 amino acid residues includingmost of the leader
peptide [16]. TorD binding to the core induces an apoTorA compe-
tent conformation allowing the insertion of the bisMGD cofactor.
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TorA, TorDalso interactswith the immature cofactor andwith anen-
zyme involved in cofactor biogenesis [17]. After insertion of the
cofactor, TorA is rapidly translocated to the periplasm [8].
TorD is part of a large family of chaperone dedicated to metallo-
proteins and generally to bisMGD-containing enzymes [12]. Mem-
bers of this large family present an all-helical architecture which is
highly conserved despite a low level of sequence identity [18–20].
Many TorD-like proteins also play a direct role in the stability and
the maturation of their molybdoenzyme partner. Like TorD, they
bind their molybdoenzymes to at least two distinct sites: the N-ter-
minal extremity and the core of the enzyme [1,11,20].
So far, neither the proteases involved in the degradation of
immature or misfolded molybdoenzymes nor the process of their
degradation are known. However, degradation of proteins in
E. coli is generally executed by ATP-dependent AAA+ (ATPases
associated with various cellular activities) proteases [21–23]. The
AAA+ proteases form large multisubunit machines with an internal
proteolytic chamber accessible to unfolded proteins only. Sub-
strates bear recognition elements named degrons, or degradation
tags, recognized by a hexameric chaperone component that un-
folds and translocates the denatured polypeptide into the proteo-
lytic chamber in an ATP-dependent manner. Contrary to the Clp
proteases which are oligomers of distinct proteins, Lon protease
is a homohexamer and each subunit consists of three domains:
one for the recognition and the binding of the substrate, followed
by the ATPase domain providing energy, and terminated by the
proteolytic domain. The recognition process of a protein by Lon
is still not elucidated and no consensus motif has been identiﬁedTable 1
Strains and plasmids used in this work.
Strain or plasmid Genotype or relevant characteristics
MC4100 araD139 D(lacIPOZYA-argF) U169 rpsL thi
DADE MC4100 DtatABCD DtatE
LCB641 MC4100 torD::X SpecR
LCB1035 MC4100 htpX::X KmR, P1 transduction from JW
LCB1036 LCB641 htpX::X KmR, P1 transduction from JW1
LCB1048 LCB641 clpS::X KmR, P1 transduction from JW0
LCB1049 MC4100 moaA::X KmR, P1 transduction from JW
LCB1050 MC4100 moaA-lon::X KmR, P1 transduction from
LCB1052 MC4100 lon::X KmR, P1 transduction from JW0
LCB1053 LCB641 lon::X KmR, P1 transduction from JW04
LCB1057 LCB641 clpA::X KmR, P1 transduction from JW0
LCB1058 LCB641 clpP::X KmR, P1 transduction from JW0
LCB1059 MC4100 clpA::X KmR, P1 transduction from JW
LCB1060 MC4100 clpP::X KmR, P1 transduction from JW
LCB1061 MC4100 clpXP::X KmR, P1 transduction from JW
LCB1062 MC4100 hslUV::X KmR, P1 transduction from JW
LCB1063 MC4100 clpS::X KmR, P1 transduction from JW0
LCB1064 MC4100 ftsH::X KmR, P1 transduction from JW3
LCB1065 LCB1052 clpXP-hslUV::X KmR, P1 transduction o
LCB1066 LCB641 clpXP::X KmR, P1 transduction from JW
LCB1067 LCB641 hslUV::X KmR, P1 transduction from JW
LCB1068 LCB641 ftsH::X KmR, -P1 transduction from JW
LCB1069 LCB1053 clpXP-hslUV::X KmR, P1 transduction o
LCB1070 LCB1049 clpXP::X KmR, P1 transduction from JW
LCB1071 LCB1049 hslUV::X KmR, P1 transduction from JW
LCB1072 LCB1049 clpA::X KmR, P1 transduction from JW
LCB1073 LCB1049 clpP::X KmR, P1 transduction from JW
LCB1074 LCB1070 lon-hslUV:: X KmR, P1 transduction fro
LCB1075 LCB1050 torD:: X KmR, P1 transduction from JW
pJF119EH Vector containing Ptac (ApR) promoter with pBR
pLon lon coding sequence inserted into pBAD24
pTorA torA coding sequence of E. coli inserted into pJF
pBAD33 Vector containing arabinose PBAD promoter (Cm
pB33A torA coding sequence inserted into pBAD33
pBAD24 Vector containing the arabinose PBAD promoter
pBD torD coding sequence inserted into pBAD24
pBDL83P torD containing L83P variant coding sequence in
JW mutants are from the Keio collection [28].so far. It has been proposed that the exposure of hydrophobic
patches rich in aromatic residues can serve as degrons [24,25].
Moreover, in vivo and in vitro studies on the stability of the regu-
lator SoxS have clearly established that the N-terminal region of
the protein is directly recognized by Lon protease leading to its
processive proteolysis [26,27].
In a previous model, we proposed that degradation of apoTorA
proceeds ﬁrst by the N-terminal extremity and then, by the core of
the protein [11]. This point raises the question of the number and
the nature of the proteases involved in TorA degradation. Here, we
investigated a possible role of AAA+ proteases in the degradation
process of the molybdoenzyme TorA. We found that Lon has a ma-
jor role in apoTorA degradation and that TorD prevents transiently
proteolysis of the apoform of the molybdoenzyme.
2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
The E. coli strains and plasmids used in this work are listed in
Table 1. pB33A is a pBAD33 derivative constructed as pTorA [31],
and pB33A and pTorA allow the synthesis of His6-tagged TorA,
and pBD and pBDL83P allowing the synthesis of His6-tagged TorD
were previously described [13,17]. pLon was kindly provided by
R.E.Wolf [26] and permits the production of N-terminal His-tagged
Lon. The strains were grown aerobically in Luria Broth medium at
37 C or 42 C. When necessary, the following were added: TMAO
(0.2%) to induced chromosomal expression of torA gene; IPTG




1818 strain This work
818 strain This work
865 strain This work
0764 strain This work
JW0764 and JW0429 strains This work
429 strain This work
29 strain This work
866 strain This work
427 strain This work
0866 strain This work
0427 strain This work
0427 and JW0428 strains This work
3902 and JW3903 strains This work
865 strain This work
145 strain This work
f JW0427, JW0428, JW3902, JW3903 strains This work
0427 and JW0428 strains This work
3902 and JW3903 strains This work
3145 strain This work
f JW0427, JW0428, JW3902, JW3903 strains This work
0427 and JW0428 strains This work
3902 and JW3903 strains This work
0866 strain This work
0427 strain This work
m JW0429, JW3902, JW3903 strains This work
0983 strain This work
origin of replication [30]
[26]
119EH [31]
R) with pACYC origin of replication [32]
This work
(ApR) with pBR origin of replication [32]
[13]
serted into pBAD24 [17]
D. Redelberger et al. / FEBS Letters 587 (2013) 3935–3942 3937derivatives, respectively; and ampicillin (50 lg/ml) and/or
chloramphenicol (25 lg/ml) to maintain plasmid selection. Induc-
tion of plasmid promoters was initiated when OD600 reached 0.8
and lasted for 3 h.
2.2. Molecular procedures
For double or triple mutant constructions, the mutations were
transferred to host strains by P1 transduction. Transformations
into recombinant strains by vectors and plasmids were carried
out according to the method of Chung and Miller [33].
2.3. Preparation of the soluble fractions
Cells were harvested, washed twice in 40 mM Tris–HCl, pH 7.6,
and disrupted by a French press. The extracts were centrifuged at
15000 rpm, with the recovered supernatants then being centri-
fuged at 45000 rpm to obtain the soluble fractions.
2.4. Puriﬁcation of recombinant proteins
HoloTorA, apoTorA, TorD and Lon are His6-tagged proteins
[12,26,31]. Puriﬁcations were performed from soluble fractions of
strains of interest by HiTrap Chelating HP chromatography (Amer-
sham Biosciences) as previously described [26,31].
2.5. Chemical cross-linking experiments
Interactions of apoTorA, TorD and Lon were tested using 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDC) as a cross-linker. Proteins (8 lM) and EDC (5 mM) in
10 mM cacodylate buffer (pH 6.0, 20 ll ﬁnal volume) were incu-
bated 30 min at room temperature. The interactions were analyzed
by SDS–12%-PAGE and were revealed by western blot using TorA
antibodies.
2.6. Surface plasmon resonance (SPR) binding experiments
A BIAcore T100 apparatus was used to investigate the interac-
tion between ApoTorA, TorA and Lon. ApoTorA 2478 RU
(Resonance Unit) or Lon 2551.4 RU were immobilized on a CM5
sensor chip (BIAcore) in 10 mM sodium acetate pH 5 by amine
coupling using a kit supplied by BIAcore. Running buffer, used
when interactions were tested, contained 20 mM phosphate buf-
fer, pH 7, 150 mM NaCl and 0.05% Tween 20 with a ﬂow rate of
30 lL/min. No ATP was present in the buffer. Samples were di-
luted in the same buffer. Increasing concentrations of the analyte
(Lon 0.125 lM; 0.25 lM; 0.375 lM; 0.5 lM; 0.75 lM; 1 lM or
ApoTorA 0.125 lM; 0.25 lM; 0.5 lM; 0.75 lM; 1 lM; 1.25 lM
or TorA 0.062 lM; 0.125 lM; 0.25 lM; 0. 5 lM; 0.75 lM; 1 lM)
were injected (association time: 300 s). The Kd value was calcu-
lated from the results of three independent experiments. Control
experiments were done on sensor chip in the absence of immobi-
lized proteins.
2.7. Analytical procedures
The TMAO reductase activity was measured spectrophotometri-
cally at 37 C by following the oxidation of reduced benzyl viologen
at 600 nm coupled to the reduction of TMAO and was expressed in
lmol TMAO reduced/min/mg proteins [10].
The amount of TorA present in the extracts was determined by
rocket immunoelectrophoresis. Samples were submitted to elec-
trophoresis at 2 mA overnight in 4  4-cm (1%, w/v) agarose plates
buffered with 20 mm sodium barbital (pH 8.6) containing TorA
antibodies (15 ll).For Western blotting, proteins were transferred to a Hybond
ECL nitrocellulose membrane. The ECL-Western blotting system
(Amersham, Pharmacia) was used for detection.
MALDI-TOF (matrix-assisted laser desorption ionization/
time-of ﬂight) mass spectrometry was performed as previously
described [16]. ApoTorA theoretical mass determination was
obtained using ExPASy server.
2.8. In vitro degradation assays
Puriﬁed apoTorA (0.05 lM) and Lon (10 lM) were pre-incu-
bated for 2 min at 37 C in the degradation buffer described in
Ref. [34] (50 mM Tris/HCl, pH 8.0; 1 mM DTT; 15 mM MgCl2; 2%
DMSO; 5 mM KCl; 25 mM HEPES, pH 8.0; 0.5 mM b-mercap-
toethanol; 10% sucrose). Degradation was started by addition of
20 mM ATP. As controls, degradation experiments were carried
out either with puriﬁed mature TorA or without addition of ATP
or Lon or with addition of 50 mM EDTA, pH 8.0 and in each case
no degradation occurs (data not shown). Activity of Lon (4.2 lM)
was checked using b-casein (15 lM) as model substrate [35]. In
crude in vitro degradation assays, the soluble fractions (300–
400 lg of proteins) of strains either LCB1075/pTorA or LCB1075/
pTorApBD or LCB1075/pTorApBDL83P were incubated in the pres-
ence or not of puriﬁed Lon (18 lM) from 0.5 to 5 h at 37 C. Sam-
ples (34 lg of proteins) were then submitted to SDS–PAGE and
revealed by western blotting using TorA polyclonal antibodies.
Quantiﬁcation of apoTorA band was done using Image QuantTM-
LAS 4000 program.3. Results
3.1. Lon is involved in the apoTorA degradation process
To ﬁnd out the proteases involved in TorA degradation, an obvi-
ous approach was to test the stability of the TorA protein in cells
devoid of one or another of the major proteases identiﬁed in
E. coli by measuring TorA enzymatic activity in the absence of TorD,
its dedicated chaperone. The involvement of the ﬁve AAA+ ATPase
family proteases ClpAP, ClpXP, HslUV, FtsH and Lon was ﬁrst stud-
ied. We also extended the experiment to ClpS, the adaptator for the
ClpAP protease, because it alters substrate preferences [36], and to
the membranous ATP-independent HtpX membrane protease. In
the presence of TorD, the TMAO reductase activity measured in
the various protease defective contexts was similar to that of the
wild type strain (from 2.64 to 3.04 lmol/min/mg, Fig. 1A). In the
absence of TorD, only the Lon mutant provided a higher level of
TMAO reductase activity (1.76 lmol/min/mg) than the control
(0.77 lmol/min/mg), suggesting that the absence of Lon leads to
a signiﬁcant decrease of TorA degradation. Combining several pro-
tease mutants with the Lon defective strain did not signiﬁcantly
improve TorA activity. This approach thus reveals that the Lon pro-
tease affects the TorA activity level (Fig. 1A). Since we have found
that during thermal stress TorA is completely degraded in the ab-
sence of TorD [13], we wanted to know if Lon is involved in the loss
of activity in this stress condition. For that, a TorD Lon mutant
was grown at 42 C. Although no TMAO reductase activity was de-
tected in a TorD strain [13], signiﬁcant TMAO reductase activity
was measurable in the TorD Lon (0.25 lmol/min/mg). Moreover,
a combined Lon ClpXP HslUVmutant presented a similar TMAO
reductase activity (0.3 lmol/min/mg), while in single mutants
ClpXP or HslUV almost no TMAO reductase activity was de-
tected, thereby conﬁrming the role of Lon in degradation of TorA.
To correlate the TMAO reductase activity levels to the amount
of TorA, the latter was estimated by immunoelectrophoresis in var-
ious lon and torD contexts. As expected, in Lonmutants, the TMAO
Fig. 1. Lon degrades apoTorA in vivo. (A) Strains MC4100 and LCB641 (TorD) and their protease defective derivatives (black and open bars, respectively) were grown
aerobically at 37 C in LB medium containing TMAO (0.2%). TMAO reductase activity was measured spectrophotometrically on soluble extracts and expressed as a percentage
of the value obtained for the wild type MC4100 extract. (B) Strains MC4100, LCB641 (TorD) were grown as in A. Strains LCB1052 (Lon), LCB1053 (TorDLon) carrying
either pBAD24 or pLon plasmids were grown as in A until an OD of 0.8, then arabinose (0.2%) was added to induce expression from the plasmid promoter for 3 h. TMAO
reductase activity (black bars) was measured and expressed as in A. The amount of TorA protein (open bars) from soluble extracts was estimated by immunoelectrophoresis
using TorA antibodies and expressed as percent relative to that produced in MC4100. (C) Western blot from soluble fractions of strains LCB1052 (Lon), LCB1053 (TorDLon),
and LCB1053/pLon in which TorA is induced by TMAO (0.2%) and Lon by arabinose (0.2%) either concomitantly (T0) or 2 h after induction of TorA synthesis (T0 + 2 h). Soluble
extracts (150 lg) were submitted to SDS–7%-PAGE and to protein transfer. The presence of TorA was revealed by using TorA antiserum. (D) Strain DADE (Tat-)/pLon was
grown as in A for 2 h, and then arabinose (0.2%) was or was not added to the medium. After 3 other hours of growth, the soluble fractions were prepared and TMAO reductase
activity was measured and expressed in lmol of TMAO reduced/min/mg of protein. (E) Western blot revealed as in C from soluble fractions (100 lg) of strain LCB1050 (MoA,
Lon) carrying either pBAD() or pLon (+) grown as in B. (F) Cleavage of the apoTorA signal peptide in various protease contexts. ApoTorA was puriﬁed from strains MoA
(Mo) and derivatives LCB1050 (Lon), LCB1070 (ClpXP), LCB1071 (HslUV), LCB1074 (ClpXP, HslUV, Lon), LCB1072 (ClpA) and LCB1073 (ClpP) carrying either plasmid
pTorA (TorD) or pTorAD (+TorD). After puriﬁcation, apoTorA mass expressed in Dalton was obtained by MALDI-TOF MS. Nd; not determined. Error bars indicate S.E.M.
(n > 3).
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the cell, indicating that Lon acts on TorA degradation and not on its
catalytic function (Fig. 1B). Moreover, the absence of both Lon andTorD (strain LCB1053) restored a high level of TorA activity and
protein (60–70% compared to MC4100). Furthermore, in the ab-
sence of TorD, the complementation of the lonmutant by a plasmid
Fig. 2. Lon interacts only with the immature form of TorA. SPR sensorgrams
obtained between apoTorA (bound ligand) and increasing concentrations of Lon
(analyte, from 0.125 to 1 lM). Inset, Lon was immobilized and ApoTorA (square) or
TorA (circle) was injected. Equilibrium response levels were plotted as a function of
analyte concentration (apoTorA or Lon). This ﬁgure is representative of three
independent experiments.
Fig. 3. Excess of TorD impairs Lon binding on apoTorA. (A) ApoTorA (8 lM) was
incubated with either TorD (8 lM) or Lon (8 lM) or both TorD (8 lM, 13 lM,
25 lM) and Lon (8 lM) in the presence of EDC (5 mM) for 30 min at room
temperature. Samples (6.6 ll) were loaded on a SDS–7%-polyacrylamide gel. After
electrophoresis, proteins were visualized by western blotting with TorA antibodies.
Arrows indicate the cross-linking between apoTorA and Lon (1) and apoTorA and
TorD (2).
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the TorD phenotype. Finally, the overproduction of Lon in strain
LCB1052 (Lon) led to a 30% decrease of TorA amount conﬁrming
that TorA is a Lon target (Fig. 1B).
To determine which form of TorA is the proper substrate for
degradation, Lon and TorA were overproduced in a TorD strain.
When synthesis of TorA and Lon was induced at the same time,
TorA was completely degraded and thus was not detected by anti-
bodies, whereas when Lon production was delayed for 2 h, the
TorA polypeptide could be visualized on the western blot
(Fig. 1C). This latter result could mean that Lon attack is an early
event starting before the maturation of TorA. To conﬁrm this
hypothesis, we used a Tat strain which produces an active TorA
trapped into the cytoplasm [8,9]. The Tat strain was grown for
2 h and its TMAO reductase activity was measured (0.14 lmol/
min/mg) (Fig. 1D). The culture was then divided into two samples
in which Lon production was or was not induced for 3 h. In the ab-
sence of Lon, TorA accumulated and the TMAO reductase activity
recovered (1.4 lmol/min/mg) was about 10 times increased, while
in the presence of Lon the TMAO reductase activity was almost un-
changed (compare 0.14 to 0.16 lmol/min/mg, Fig. 1D). This exper-
iment indicates that when the molybdenum cofactor is inserted,
the mature protein becomes resistant to Lon degradation. Finally,
a control with a strain defective in Moco biosynthesis indicated
that overproduction of Lon leads to the complete loss of apoTorA
in the cytoplasmic fraction even in the presence of the TorD chap-
erone (Fig. 1E).
Our hypothesis is that degradation of the apoenzyme is a two-
step mechanism, involving the degradation of the leader peptide
followed by the proteolysis of the globular part of the apoprotein
[17]. To test this model and to determine whether Lon is involved
in both steps, the mass of the apoprotein overexpressed and puri-
ﬁed from a MocoTorDLon strain (LCB1075) was analyzed by
MALDI-TOF MS. The mass obtained was 91379 Da corresponding
to the apoprotein truncated of its N-terminal part (Fig. 1F). This
indicates that the lack of Lon does not prevent the loss of the ﬁrst
35 residues of the protein and consequently that Lon is rather
responsible for the degradation of the globular part of the TorA
protein. Furthermore, when apoTorA is produced and puriﬁed in
the absence of TorD from strains also devoid of either HslUV or
the Clp proteins, the molecular mass obtained corresponded to a
truncated apoenzyme (Fig. 1F). As expected, when apoTorA was
produced in the presence of TorD the leader peptide was not
degraded.
3.2. ApoTorA interacts with Lon
The ﬁrst set of results suggests that Lon recognizes only the core
of apoTorA. To conﬁrm this point, a surface plasmon resonance
(SPR) experiment was carried out to follow, in real time, the inter-
action between Lon and the apo or holo form of TorA. The data
show an interaction between Lon and apoTorA (Fig. 2). Moreover,
this data set shows the formation of a very stable complex between
Lon and apoTorA. The determination of the equilibrium constant
level (Req) at different concentrations allows us to estimate after
three independent experiments a Kd of 1.0 ± 0.2 lM. In contrast,
no interaction was detected with holoTorA (Fig. 2 inset) conﬁrming
that the protease binds the core of TorA only in the absence of the
cofactor.
By chemical cross linking, it was possible to study the competi-
tion between Lon and TorD towards apoTorA. The appearance of a
band in the gel when ApoTorA and Lon were mixed and incubated
in the presence of EDC, a chemical cross linker, conﬁrms this inter-
action (Fig. 3, arrow 1). The addition of TorD in the Lon-apoTorA
mix in a 1:1:1 ratio led to the appearance of an additional band
in the gel (Fig. 3, arrow 2), revealing that apoTorA binds either TorDor Lon. When the TorD concentration was increased three-fold, the
TorD-apoTorA binding was predominant (Fig. 3), showing that
TorD in excess prevents Lon binding to apoTorA.
3.3. ApoTorA is a Lon substrate in vitro
ApoTorA proteolysis by Lon was investigated by carrying out a
puriﬁed degradation assay. This assay was adapted from those de-
scribed in the literature and contained puriﬁed apoTorA and Lon in
the presence of ATP. In this assay, 50% of the apoTorA pool was de-
graded in 3 h and more than 70% after an incubation of 5 h
(Fig. 4A). The absence of Lon in the puriﬁed assay showed that apo-
TorA was quite stable since 80% of the apoTorA pool was still de-
tected in the sample after 5 h (Fig. 4A). bcaseine, a known Lon
substrate, was used to test the reliability of this in vitro puriﬁed as-
say and as expected, the protein was rapidly degraded (Fig. 4B). A
crude in vitro system was also performed to test a possible
improvement of the degradation process efﬁciency. ApoTorA was
overproduced in a Moco, TorD and Lon defective strain, and the sol-
uble fraction of this strain was used as apoTorA source. Strikingly,
when puriﬁed Lon protease was added, 64% of the apoTorA pool
was degraded in 1 h and, after 5 h, about 80% of the apoprotein
was eliminated (Fig. 4C). When no Lon was added in the control as-
say, an incubation of 1 h did not affect apoTorA stability and the
Fig. 4. Lon degrades apoTorA in vitro. (A) Puriﬁed apoTorA protein (0.05 lM) was incubated either with puriﬁed Lon protein (10 lM) or alone in the presence of ATP (20 mM)
at 37 C in a puriﬁed degradation assay. After incubation (3 and 5 h), the samples (2.7 ll) were submitted to SDS–12%-PAGE and apoTorA was revealed by Western blotting
using TorA antibodies. Quantiﬁcation of apoTorA band was performed using Image QuantTMLAS 4000 program. (B) The degradation assay was tested by incubating bcaseine
(15 lM) with Lon (4.2 lg) for 15 min or 5 h in the same assay as in A. After SDS–15%-PAGE, proteins (loading 3 lg) were revealed by Coomassie brilliant blue. M: molecular
weight markers. (C–E) The soluble fractions (from 300-450 lg of proteins) containing either apoTorA (C) or apoTorATorD (D) or apoTorATorDL83P (E) were incubated in the
presence or not of puriﬁed Lon protein (18 lM) at 37 C. ApoTorA degradation was visualized and quantiﬁed as in A. Error bars indicate S.E.M. (n > 3).
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compared to that obtained in the presence of Lon (80%) (Fig. 4C).
3.4. TorD impairs Lon activity by binding to apoTorA
The crude assay was used to probe whether a TorD mutant that
does not interact with TorA could still protect apoTorA. For that,
Lon protein was ﬁrst mixed with a soluble fraction in which both
TorD and apoTorA were overproduced. The presence of TorD main-
tains almost 70% of the apoprotein in the sample after 1 h incuba-
tion, and after 5 h, 60% of the protein was detected (Fig. 4D). In a
second sample, production of TorD was replaced by that of
TorDL83P, a variant protein which was previously shown to be
defective for binding to the core of the apoprotein [17]. In this case,
a degradation pattern similar to that obtained in the absence of
TorD was observed (compare Fig. 4E and C). This result is in perfect
agreement with the lack of TorDL83P protective role towards apoTo-
rA under condition of thermal stress [17] and it clearly shows that
TorD binding is required for apoTorA protection against Lon
dagradation.
4. Discussion
We have demonstrated in previous works that apoTorA degra-
dation is a two-step process: the N-terminal extremity includingthe signal sequence is submitted to a ﬁrst cleavage and then, the
core of the protein is degraded. According to the nature of the N-ter-
minal extremity of apoTorA in both its native (MNNND) and trun-
cated (RATAA) forms [16], the N-end rule pathway mediated by
the ClpAP-ClpS machinery could have been a process potentially
implicated in TorA degradation, since arginine and methionine
are described as possible secondary destabilizing residues [21].
Our results indicate that in the absence of the ClpP protease, the
N-terminal end of TorA apoform is still degraded (Fig. 1F) and that
a deletion of neither ClpAP nor ClpS adaptor increases apoTorA sta-
bility (Fig. 1A). This suggests that apoTorA is not a substrate for the
N-end rule pathway and that furthermore the cleavage of the ﬁrst
35 residues by a still unknown endopeptidase is not an initial pro-
cessing event generating an N-degron [37]. In the same line of
thought, Lon or HslUV are also not involved in the proteolytic pro-
cessing of the N-terminal extremity since even in the absence of
these proteases, the N-terminal part of the apoenzyme is truncated
(Fig. 1F). So far, the proteolytic event leading to the loss of apoTorA
N-terminal end has not been elucidated.
To our knowledge, the identity of proteases involved in the
turnover of molybdoenzymes has never been investigated. Inter-
estingly, ours results clearly show that Lon is responsible for the
degradation of the apoTorA core. The stability of apoTorA requires
the presence of its dedicated chaperone TorD. When the latter is
missing, the apoprotein is rapidly degraded. To ﬁnd out the nature
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context. We observed that under these conditions the absence of
Lon only leads to a signiﬁcant increase of apoTorA stability. None
of the other protease defective strain tested recovered a TMAO
reductase activity close or similar to the level measured in the
TorD+ strain. However, it is noteworthy that in the absence of
Lon and TorD, we did not recover 100% of TorA activity level and
that about 30% of TorA was still degraded (Fig. 1A and B). This sug-
gests that another protease can take over the apoTorA degradation.
Moreover, the overproduction of Lon leads to a moderate decrease
in TorD protection (Fig. 1B).
The involvement of Lon in the degradation process of apoTorA
was directly established by the in vitro assay. When the assays
were carried out without adding Lon, apoTorA was stable for sev-
eral hours whereas in the presence of the protease, the degradation
process occurs rapidly (Fig. 4A). During the course of this work, we
wondered whether an endopeptidase could be involved at the ﬁrst
step of the apoTorA core degradation. Since we never found a sta-
ble intermediate form of apoTorA in the absence of Lon, and since
no other protein was present in the puriﬁed system, this led us to
reconsider this hypothesis. Although Lon is described as a proces-
sive enzyme, it was recently discovered that it is able to unfold a
hydrophobic region and can initiate degradation from an internal
degron ﬂanked by native protein domains [38]. We thus propose
that the degradation process of apoTorA starts by Lon recognition
of an internal hydrophobic patch and that Lon, like other AAA+ pro-
teases, translocates two polypeptide strands in its proteolytic
chamber as suggested by Gur and coworkers [38]. Furthermore,
the direct interaction revealed by SPR experiments indicates that
no adaptor protein is necessary and that binding occurs between
the apoform of TorA and the Lon protease, while the holoprotein
was not recognized (Fig. 2). The insertion of the molybdenum
cofactor at the catalytic site of the enzyme stops Lon from interact-
ing with TorA and thus protects TorA from Lon proteolytic attack.
When the TAT translocation machinery is missing, the pre-holo-
protein trapped in the cytoplasm is not degraded, thereby conﬁrm-
ing that the insertion of the molybdenum cofactor at TorA catalytic
site impairs Lon activity. Therefore, it is the loss of recognition by
Lon, due to molybdenum cofactor insertion, rather than the subcel-
lular translocation of TorA which makes the latter resistant to pro-
teolysis. Altogether these results strongly suggest that the absence
of the bisMGD at the catalytic site of the enzyme unmasks targets
for the protease, and one hypothesis is that TorD hides the protease
sensible patches of the protein either directly or by folding apoTo-
rA. This last point also supports our previous proposal of a TorD
binding site in the vicinity of the TorA catalytic site, since it has
been demonstrated that TorD binds the mature form of the molyb-
denum cofactor [17].
During apoTorA synthesis and folding, TorD binding occurs
probably prior Lon recognition. The cross-linking experiments
show that both TorD and Lon interact with apoTorA, but that the
presence of one partner excludes the other (Fig. 3). Moreover,
when both apoTorA partners are included in the crosslinking assay,
a balance between the two possible complexes appears, i.e. apoTo-
rA-TorD and apoTorA-Lon. According to the ligand concentrations,
the equilibrium shifts towards one or the other complex. These
data suggest that the binding sites for the two proteins either over-
lap or are close enough for the proteins to exclude each other.
Moreover, using a TorD variant unable to bind the core of apoTorA
in the in vitro degradation assay, we demonstrated that the bind-
ing between apoTorA and the chaperone is required for the protec-
tion and that unbound TorD does not inhibit Lon activity.
In conclusion, we propose a model in which the apoform of
TorA is protected by a speciﬁc interaction with the TorD chaperone.
This interaction probably occurs in the vicinity of the molybdenum
cofactor insertion zone in the core of TorA and masks hydrophobicpatches. The latter serve as ligands for the cofactor but also as rec-
ognition degrons for the protease when the cofactor is missing.
Since the torA and torD genes are part of the same transcription
unit, their expression is concomitant and TorD can protect its bulky
partner as soon as it is produced. When several molybdoenzymes
are synthesized at the same time, the cofactor becomes limiting
in the bacteria and the amount of apoTorA decreases even in the
presence of TorD [14]. This indicates that the interaction between
the chaperone and the molybdoenzyme is a dynamic process and
that the apoform is only transiently protected in vivo suggesting
a Lon-dependent turnover of the immature or misfolded TorA.
The model is in agreement with Lon exhibiting a dual role in pro-
tein quality control and cellular physiology in bacteria [23,24].
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